PTGS2 and neoplasm: Kużbicki et al. developed an immunohistochemical scoring methodology, which demonstrates the significance of cyclooxygenase-2 as a negative prognostic factor for melanoma, directly associated with other relevant prognostic variables, including ulceration, lymph node metastasis, and tumor thickness [94].